Applied Energetics, Inc. (AERG) shareholders
Close on Oct 19, 2026Market cap $195.80MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ingalls & Snyder LLC | 17,230,596 | 7.70% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AERG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Game Plan Financial Advisors, LLC | 100 | – | $134 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2024 | 2 | 0M | 0 / 1 | 0 / 0 | 0M | 0M |
| Q3 2024 | 2 | 0M | 0 / 0 | 1 / 1 | 0M | 0M |
| Q2 2024 | 3 | 0M | 0 / 1 | 1 / 0 | 0M | 0M |
| Q1 2024 | 3 | 0M | 0 / 0 | 1 / 0 | 0M | 1M |
| Q4 2023 | 3 | 1M | 1 / 1 | 0 / 2 | 0M | 0M |
| Q3 2023 | 4 | 1M | 1 / 1 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1 funds held AERG in Q2 2026. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of AERG | Value | % of fund | As of |
|---|---|---|---|---|---|
| Boston Partners Long/Short Equity Fund | -68,299 | – | -$92.20K | -0.07% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Christopher Wayne Donaghey | President & CEO, Director | 173,742 | Aug 26, 2026 |
| Gregory James Quarles | CEO Emeritus, Director | 0 | Jan 23, 2026 |
| Mary Payton O'Hara | General Counsel and CLO, Director | – | May 22, 2025 |
| Stephen William McCahon | Chief Science Officer | 12,772,861 | Oct 6, 2026 |
| Warren Jeffrey Spector | Chief Financial Officer | – | Feb 18, 2026 |
| David Edgar Spence | Chief Product Officer | – | Nov 19, 2025 |
| Bradford Thomas Adamczyk | Director | 2,235,081 | Jun 10, 2026 |
| Allen Scott Andrews | Director | 1,298,775 | Oct 7, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Christopher Wayne Donaghey President & CEO, Director | Jul 13, 2026 | Tax withholding | −39,850 | – | – | 173,742 |
| Christopher Wayne Donaghey President & CEO, Director | Jul 13, 2026 | Option exercise | −100,000 | – | – | 213,592 |
| Bradford Thomas Adamczyk Director | Jun 8, 2026 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 671,482 |
| Bradford Thomas Adamczyk Director | Jun 8, 2026 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Christopher Wayne Donaghey President & CEO, Director | Jun 1, 2026 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 113,592 |
| Bradford Thomas Adamczyk Director | May 11, 2026 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Bradford Thomas Adamczyk Director | May 11, 2026 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 671,482 |
| Christopher Wayne Donaghey President & CEO, Director | May 11, 2026 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 123,592 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Jan 26, 2026 | Sale(10b5-1 plan) | −10,000 | $1.65 | $16.50K | 133,592 |
| Gregory James Quarles CEO Emeritus, Director | Jan 21, 2026 | Sale(10b5-1 plan) | −6,600 | $1.87 | $12.34K | 0 |
| Gregory James Quarles CEO Emeritus, Director | Jan 21, 2026 | Option exercise | +6,600 | $0.35 | $2.31K | 6,600 |
| Stephen William McCahon Chief Science Officer | Jan 20, 2026 | Sale(10b5-1 plan) | −10,000 | $1.80 | $18.00K | 12,772,861 |
| Bradford Thomas Adamczyk Director | Jan 7, 2026 | Sale(10b5-1 plan) | −10,000 | $1.77 | $17.70K | 671,482 |
| Bradford Thomas Adamczyk Director | Jan 7, 2026 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Dec 29, 2025 | Sale(10b5-1 plan) | −7,700 | $1.93 | $14.86K | 143,592 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Dec 26, 2025 | Sale(10b5-1 plan) | −2,300 | $1.92 | $4.42K | 151,292 |
| Stephen William McCahon Chief Science Officer | Dec 22, 2025 | Sale(10b5-1 plan) | −10,000 | $1.86 | $18.60K | 12,782,861 |
| Gregory James Quarles CEO Emeritus, Director | Dec 22, 2025 | Option exercise | +10,000 | $0.35 | $3.50K | 10,000 |
| Gregory James Quarles CEO Emeritus, Director | Dec 22, 2025 | Sale(10b5-1 plan) | −10,000 | $1.88 | $18.80K | 0 |
| Bradford Thomas Adamczyk Director | Dec 8, 2025 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Bradford Thomas Adamczyk Director | Dec 8, 2025 | Sale(10b5-1 plan) | −10,000 | $1.86 | $18.60K | 671,482 |
| Gregory James Quarles CEO Emeritus, Director | Dec 4, 2025 | Option exercise | +10,000 | $0.35 | $3.50K | 10,000 |
| Gregory James Quarles CEO Emeritus, Director | Dec 4, 2025 | Sale(10b5-1 plan) | −10,000 | $1.77 | $17.70K | 0 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Nov 28, 2025 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 153,592 |
| Stephen William McCahon Chief Science Officer | Nov 21, 2025 | Sale(10b5-1 plan) | −8,900 | $1.51 | $13.44K | 12,792,861 |
| Stephen William McCahon Chief Science Officer | Nov 19, 2025 | Sale(10b5-1 plan) | −1,100 | $1.50 | $1.65K | 12,801,761 |
| Bradford Thomas Adamczyk Director | Nov 17, 2025 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Bradford Thomas Adamczyk Director | Nov 17, 2025 | Sale(10b5-1 plan) | −10,000 | $1.58 | $15.80K | 671,482 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Oct 27, 2025 | Sale(10b5-1 plan) | −10,000 | $1.68 | $16.80K | 163,592 |
| Stephen William McCahon Chief Science Officer | Oct 20, 2025 | Sale(10b5-1 plan) | −10,000 | $1.65 | $16.50K | 12,802,861 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Sep 25, 2025 | Sale(10b5-1 plan) | −10,000 | $2.00 | $20.00K | 173,592 |
| Gregory James Quarles CEO Emeritus, Director | Sep 24, 2025 | Option exercise | +10,000 | $0.35 | $3.50K | 10,000 |
| Gregory James Quarles CEO Emeritus, Director | Sep 24, 2025 | Sale(10b5-1 plan) | −10,000 | $1.92 | $19.20K | 0 |
| Bradford Thomas Adamczyk Director | Sep 19, 2025 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Bradford Thomas Adamczyk Director | Sep 19, 2025 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 671,482 |
| Stephen William McCahon Chief Science Officer | Sep 19, 2025 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 12,812,861 |
| Bradford Thomas Adamczyk Director | Aug 15, 2025 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Bradford Thomas Adamczyk Director | Aug 15, 2025 | Sale(10b5-1 plan) | −10,000 | $1.76 | $17.60K | 671,482 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Aug 5, 2025 | Sale(10b5-1 plan) | −10,000 | $1.98 | $19.80K | 183,592 |
| Gregory James Quarles CEO Emeritus, Director | Jul 21, 2025 | Sale(10b5-1 plan) | −10,000 | $2.25 | $22.50K | 0 |
| Gregory James Quarles CEO Emeritus, Director | Jul 21, 2025 | Option exercise | +10,000 | $0.35 | $3.50K | 10,000 |
| Bradford Thomas Adamczyk Director | Jul 15, 2025 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Bradford Thomas Adamczyk Director | Jul 15, 2025 | Sale(10b5-1 plan) | −10,000 | $2.33 | $23.30K | 671,482 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Jul 15, 2025 | Tax withholding | −37,435 | $2.27 | $84.98K | 193,592 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Jul 13, 2025 | Option exercise | +100,000 | – | – | 231,027 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Jul 8, 2025 | Sale(10b5-1 plan) | −2,500 | $2.22 | $5.55K | 131,027 |
| Christopher Wayne Donaghey President & CEO/Principal AO, Director | Jul 7, 2025 | Sale(10b5-1 plan) | −7,500 | $2.23 | $16.73K | 133,527 |
| Gregory James Quarles CEO Emeritus, Director | Jun 23, 2025 | Option exercise | +10,000 | $0.35 | $3.50K | 10,000 |
| Gregory James Quarles CEO Emeritus, Director | Jun 23, 2025 | Sale(10b5-1 plan) | −10,000 | $2.16 | $21.60K | 0 |
| Bradford Thomas Adamczyk Director | Jun 12, 2025 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Bradford Thomas Adamczyk Director | Jun 12, 2025 | Sale(10b5-1 plan) | −10,000 | $1.87 | $18.70K | 671,482 |
| Christopher Wayne Donaghey President & CEO/Principal AO | Jun 5, 2025 | Sale(10b5-1 plan) | −10,000 | $2.33 | $23.30K | 141,027 |
| Gregory James Quarles CEO Emeritus, Director | May 28, 2025 | Option exercise | +10,000 | $0.35 | $3.50K | 10,000 |
| Gregory James Quarles CEO Emeritus, Director | May 28, 2025 | Sale(10b5-1 plan) | −10,000 | $1.92 | $19.20K | 0 |
| Bradford Thomas Adamczyk Executive Chairman, Director | May 22, 2025 | Option exercise | +10,000 | $0.07 | $700 | 681,482 |
| Bradford Thomas Adamczyk Executive Chairman, Director | May 22, 2025 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 671,482 |
| Christopher Wayne Donaghey President & CEO/Principal AO | May 21, 2025 | Sale(10b5-1 plan) | −10,000 | $1.50 | $15.00K | 151,027 |
| Christopher Wayne Donaghey CFO/COO | Jul 13, 2024 | Tax withholding | −37,532 | – | – | 161,027 |
| Christopher Wayne Donaghey CFO/COO | Jul 13, 2024 | Option exercise | +100,000 | – | – | 198,559 |
| Gregory James Quarles President and CEO, Director | Jun 21, 2024 | Option exercise | +9,500 | $0.35 | $3.33K | 10,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Applied Energetics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1 shares on Sep 16, 2026 over the last 90 days.
See a number that looks wrong?